Company Search:
Advanced Search
Sponsored Links
BrightPath Biotherapeutics Co Ltd Company Snapshot
BrightPath Biotherapeutics Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BrightPath Biotherapeutics Co Ltd with three other companies in this sector in Japan: Nanocarrier Company Limited (2018 sales of 259.10 million Japanese Yen [US$2.36 million] of which 100% was Research and Development), DNA Chip Research, Inc. (362.84 million Japanese Yen [US$3.31 million] ), and D.Western Therapeutics Institute Incorporation (292.92 million Japanese Yen [US$2.67 million] of which 100% was Innovative drug).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BrightPath Biotherapeutics Co Ltd
  Stock Performance Chart for BrightPath Biotherapeutics Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (5/17/2019): 263.00
(Figures in Japanese Yen)
1 Week -9.9%   13 Weeks -11.7%  
4 Weeks -6.4%   52 Weeks -52.8%  
BrightPath Biotherapeutics Co Ltd Key Data:
  Ticker: 4594 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 354,410,000
(Year Ending Jan 2019).
Employees: 42
  Currency: Japanese Yen Market Cap: 11,044,290,500
  Fiscal Yr Ends: March Shares Outstanding: 41,993,500
  Share Type: Common Closely Held Shares: 1,090,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.